On Tuesday, HC Wainwright initiated coverage on Alpha Cognition Inc (NASDAQ:ACOG), noting a new twist on a tried-and-tested treatment paradigm. Alpha Cognition’s lead product, Zunveyl (benzgalantamine ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq ...
Link to Register: https://us06web.zoom.us/webinar/register/WN_5W_rY9BrSZ2eqv3dp_FqoQ About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating ...
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
To participate in the conference call, please use the dial-in information below: Participant Listening: 1-877-407-9039 or 1-201-689-8470 or https://callme.viavid.com ...
Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Greetings and welcome to the Alpha Cognition earnings call. At this time, all participants are ...
Alpha Cognition (NASDAQ:ACOG – Get Free Report) is one of 300 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors?
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating ...
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results